Advanced ID: Leprosy: Tuberculoid vs Lepromatous for MRCP Part 1
- Crack Medicine

- 9 hours ago
- 4 min read
TL;DR
Advanced ID: Leprosy: Tuberculoid vs Lepromatous is a classic MRCP Part 1 topic because it combines infectious diseases, immunology, neurology and dermatology into one high-yield exam theme. Tuberculoid leprosy reflects strong cell-mediated immunity with few organisms, whereas lepromatous leprosy reflects weak immunity with diffuse disease and high bacillary burden. Understanding the spectrum, nerve involvement and lepra reactions is far more useful than memorising isolated facts.
Why leprosy matters in MRCP Part 1
Leprosy frequently appears in questions involving:
Chronic skin lesions
Peripheral neuropathy
Granulomatous disease
Acid-fast bacilli
Immune-mediated reactions
Tropical and migrant medicine
The exam often tests the spectrum concept:
Strong immunity → tuberculoid disease
Weak immunity → lepromatous disease
This single framework explains most clinical findings.
Understanding the organism
Mycobacterium leprae is:
A slow-growing acid-fast bacillus
Obligate intracellular
Unable to grow on standard culture media
Predominantly affecting cooler body regions
Commonly involved sites
Skin
Peripheral nerves
Nasal mucosa
Earlobes
Extremities
High-yield MRCP point
M. leprae has a predilection for cooler tissues, explaining peripheral nerve and skin involvement.
The immunological spectrum
The type of leprosy depends largely on the host T-cell response.
Tuberculoid leprosy
Strong cell-mediated immunity
Few bacilli
Localised disease
Lepromatous leprosy
Poor cell-mediated immunity
Numerous organisms
Diffuse systemic involvement
This spectrum is one of the most frequently tested infectious disease concepts in MRCP-style questions.
Tuberculoid vs Lepromatous Leprosy
Feature | Tuberculoid Leprosy | Lepromatous Leprosy |
Immunity | Strong cell-mediated | Weak cell-mediated |
Bacillary load | Low | High |
Skin lesions | Few and well-defined | Numerous and diffuse |
Sensory loss | Early and marked | More gradual |
Peripheral nerves | Asymmetric involvement | Symmetric involvement |
Acid-fast bacilli | Rare | Numerous |
Lepromin test | Positive | Negative |
Histology | Granulomas | Foamy macrophages |
Infectivity | Low | Higher |
Facial involvement | Rare | Leonine facies possible |
This comparison table is worth revising repeatedly before the exam.
Five most tested subtopics
1. Skin lesions
Tuberculoid disease
Typical lesions are:
Hypopigmented
Dry
Well-demarcated
Anaesthetic
A classic exam stem describes:
“A hypopigmented anaesthetic plaque with thickened peripheral nerves.”
Lepromatous disease
Typical lesions are:
Diffuse
Nodular
Symmetrical
Poorly demarcated
Patients may develop:
Facial infiltration
Loss of eyebrows
Leonine facies
2. Peripheral nerve involvement
Neuropathy is central to the diagnosis of leprosy.
Common nerves affected
Ulnar nerve
Common peroneal nerve
Posterior tibial nerve
Greater auricular nerve
Tuberculoid disease
Localised nerve enlargement
Early sensory loss
Asymmetric neuropathy
Lepromatous disease
Symmetric neuropathy
Glove-and-stocking pattern
More widespread involvement
Important clinical clue
Palpably thickened peripheral nerves are highly characteristic of leprosy.
3. Histology and staining
Tuberculoid histology
Granulomatous inflammation
Epithelioid histiocytes
Langhans giant cells
Few bacilli
Lepromatous histology
Numerous acid-fast bacilli
Foamy macrophages
“Globi” of organisms
High-yield fact
Ziehl–Neelsen staining is much more likely to demonstrate organisms in lepromatous disease.
4. Lepra reactions
These are highly testable because they combine immunology with acute clinical deterioration.
Type 1 reaction
Delayed hypersensitivity reaction
Usually occurs in borderline disease
Existing lesions become swollen and inflamed
Risk of permanent nerve damage
Type 2 reaction (Erythema Nodosum Leprosum)
Occurs mainly in lepromatous disease.
Features:
Painful erythematous nodules
Fever
Arthralgia
Systemic inflammation
Important MRCP association
Thalidomide is effective for ENL but is teratogenic and contraindicated during pregnancy.
Further WHO guidance:https://www.who.int/teams/global-leprosy-programme
5. Treatment regimens
Paucibacillary disease
Rifampicin
Dapsone
Multibacillary disease
Rifampicin
Dapsone
Clofazimine
WHO multidrug therapy recommendations:https://www.who.int/publications/i/item/9789290228509
Drug side effects commonly tested in MRCP Part 1
Drug | Important side effect |
Dapsone | Haemolysis, methaemoglobinaemia |
Clofazimine | Skin discolouration |
Rifampicin | Hepatotoxicity, orange secretions |
High-yield pharmacology point
Dapsone may precipitate haemolysis in G6PD deficiency.
For pharmacology revision and infectious diseases lectures: https://www.crackmedicine.com/lectures
10 high-yield revision points
M. leprae prefers cooler tissues.
Tuberculoid disease has strong T-cell immunity.
Lepromatous disease has a high bacillary burden.
Anaesthetic plaques suggest tuberculoid disease.
Diffuse nodules suggest lepromatous disease.
Thickened peripheral nerves are characteristic.
Lepromin test is positive in tuberculoid disease.
ENL occurs in lepromatous leprosy.
Acid-fast bacilli are abundant in lepromatous disease.
Multidrug therapy prevents resistance.
Mini-case MCQ
A 42-year-old man from India presents with multiple symmetrical nodular skin lesions, nasal congestion and glove-and-stocking sensory loss. Skin biopsy reveals numerous acid-fast bacilli within macrophages.
What is the most likely diagnosis?
A. Tuberculoid leprosyB. Borderline tuberculosisC. Lepromatous leprosyD. SarcoidosisE. Cutaneous lupus
Answer: C. Lepromatous leprosy
Explanation
This patient demonstrates classic features of lepromatous disease:
Symmetrical skin lesions
Diffuse neuropathy
Nasal involvement
Numerous organisms on biopsy
Tuberculoid disease instead presents with:
Few lesions
Strong immunity
Sparse bacilli
Localised neuropathy
Practise more infectious diseases questions here:https://www.crackmedicine.com/qbank

Practical study checklist for MRCP Part 1
Use this checklist before the exam:
Learn the disease spectrum rather than memorising lists.
Compare tuberculoid and lepromatous disease side-by-side.
Revise peripheral nerve anatomy.
Memorise lepra reactions.
Recognise ENL associations.
Learn key drug toxicities.
Review image-based dermatology questions.
Focus on sensory findings in skin lesions.
Understand bacillary burden differences.
Practise timed infectious disease blocks regularly.
You can also test yourself with mock exams: https://www.crackmedicine.com/mock-tests
Five common pitfalls
Confusing the lepromin test with a diagnostic test.
Forgetting that tuberculoid disease contains very few organisms.
Missing asymmetric nerve involvement as a clue to tuberculoid disease.
Confusing ENL with ordinary erythema nodosum.
Assuming all acid-fast bacilli behave similarly to Mycobacterium tuberculosis.
Related topics worth revising
Leprosy overlaps closely with:
Tuberculosis
Sarcoidosis
Peripheral neuropathies
HIV-associated skin disease
Vasculitic dermatology
Useful related revision:
FAQs
Is leprosy still relevant for MRCP Part 1?
Yes. It remains highly testable because it integrates infectious diseases, immunology, dermatology and neurology into one clinically important condition.
What is the key difference between tuberculoid and lepromatous leprosy?
Tuberculoid disease has strong cell-mediated immunity with few bacilli, whereas lepromatous disease has poor immunity with diffuse infection and numerous organisms.
Which form of leprosy is more infectious?
Lepromatous leprosy is more infectious because patients carry a significantly higher bacillary load.
What causes erythema nodosum leprosum?
ENL is a type 2 immune-mediated lepra reaction that occurs mainly in lepromatous disease and causes painful inflammatory nodules with systemic symptoms.
Which peripheral nerves are commonly affected in leprosy?
The ulnar, common peroneal and posterior tibial nerves are commonly involved. Thickened nerves are a classic clinical clue.
Ready to start?
Strengthen your preparation with structured revision via the MRCP Part 1 overview. Practise actively using the Free MRCP MCQs and simulate exam conditions with a Start a mock test.
For deeper understanding, combine this guide with lecture-based revision at:https://www.crackmedicine.com/lectures/
Sources
MRCP(UK) syllabus
World Health Organization Global Leprosy Programme
WHO leprosy treatment guidance
NHS overview of leprosy
DermNet NZ – Leprosy



Comments